Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):25–30. doi: 10.1097/QAI.0b013e31823d3aba

Table 1.

Baseline characteristics of patients initiating ART who were screened for TB with sputum cultures in Durban, South Africa, 2007-2008*

Characteristic Overall
N=951
TB Sputum Culture
Positive at Enrollment
N=144
On TB Treatment
at Enrollment
N=199
TB-Free
at Enrollment
N=608
Demographic characteristics
Female (N, %) 560 (59) 78 (54) 121 (61) 361 (59)
Age, in years, median (IQR) 36 (31– 43) 37 (31– 43) 34 (30 – 41) 37 (31– 43)
Unemployed (N, %) 476 (50) 68 (47) 111 (56) 297 (49)
Married (N, %) 181 (19) 24 (17) 33 (17) 124 (20)
HIV-related characteristics
Baseline CD4 count/μl, median (IQR) 90 (41–148) 80 (41 – 125) 65 (29 – 112) 104 (49 – 160)
WHO Stage 3 or 4 (N, %) 627 (66) 98 (68) 171 (86) 358 (59)
History of OI (N, %) 497 (52) 69 (48) 113 (57) 315 (52)
Other baseline clinical characteristics
Prior history of TB (N, %) 245 (26) 28 (19) 47 (24) 170 (28)
Hospitalized in last 5 years (N, %) 251 (26) 26 (18) 68 (34) 157 (26)
Household member with history of TB
(N, %)
229 (24) 33 (23) 51 (26) 145 (24)
Baseline hemoglobin, median (IQR) 11.1 (9.5-12.6) 10.2 (8.5 – 11.8) 10.3 (9.2 – 11.8) 11.6 (10.0 – 13.0)
Baseline weight (kg), median (IQR) 61 ( 53 – 72) 57 ( 51 – 65) 60 ( 52 – 66) 63 ( 55 – 75)
Current or past smoker (N, %) 264 (28) 47 (33) 54 (27 ) 163 (27)
*

Excludes 84 patients who were screened but who were taking ART at study entry

Prior history indicates self-reported TB episode that precedes either current or new episode

TB: Tuberculosis; IQR: Inter-quartile range; WHO: World Health Organization; OI: Opportunistic infection; ART: antiretroviral therapy; kg: kilogram